S169 - Day 1 - 0930 - Taking NHS expertise overseas, preparation, prospects and pitfalls

  • 198 views
Uploaded on

Health and Care Innovation Expo 2014, Pop-up University …

Health and Care Innovation Expo 2014, Pop-up University

S169 - Day 1 - 0930 - Taking NHS expertise overseas, preparation, prospects and pitfalls

Prof Rory Shaw
Dr Geoff Hall
Dr David Rhodes
Prof Sian Griffiths

#Expo14NHS

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
198
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Seminar S169 Taking NHS expertise overseas – preparation, prospects and pitfalls Chairman: Professor Rory Shaw MD MBA FRCP Medical Director Healthcare UK
  • 2. Taking NHS expertise overseas – preparation, prospects and pitfalls Chairman: Professor Rory Shaw MD MBA FRCP Medical Director Healthcare UK
  • 3. Taking NHS expertise overseas – preparation, prospects and pitfalls • Welcome to our overseas guests from the People’s Republic of China representing: • Shandong • International Health Exchange and Cooperation Centre (IHECC), Ministry of Health
  • 4. Taking NHS expertise overseas – preparation, prospects and pitfalls 09:30 Introduction and welcome Taking NHS Expertise overseas Prof Rory Shaw Establishing an international collaboration for research, education and training - experience with King Hussein Cancer Centre, Jordan Dr Geoff Hall Associate Medical Director for Cancer Services, Leeds Cancer Centre Global opportunities in public health Dr David Rhodes Public Health England Observations and opportunities: a perspective from Hong Kong Prof Sian Griffiths Centre for Global Health, Hong Kong Panel discussion and Q&A Prof Shaw, Dr Hall, Dr Rhodes, Prof Griffiths Summary and round-up Prof Shaw 10:30 Seminar closes
  • 5. Expertise from the NHS, DH and UKTI brought together Understanding of the requirements of overseas health systems In-depth knowledge of the NHS, private sector and academia
  • 6. To help British organisations to expand overseas, Healthcare UK will: share qualified market intelligence disseminate opportunities throughout the network catalyse the creation of UK consortia enable entry into overseas markets through campaigns
  • 7. Establishing an international collaboration for research, education and training - experience with King Hussein Cancer Centre, Jordan Dr Geoff Hall Associate Medical Director for Cancer Services, Leeds Cancer Centre
  • 8. Establishing an international collaboration for research, education and training The Leeds Experience with the King Hussein Cancer Centre, Jordan Dr Geoff Hall Associate Medical Director for Cancer Services, Leeds Cancer Centre
  • 9. Leeds Cancer Centre • Leeds Teaching Hospitals Trust • One of UK’s largest Trusts • 1,950 beds, 1.2 million patients/year, £1 billion budget • 800 consultants, 14,000 staff • St James’s Institute of Oncology – clinical care / trials • Opened in 2008, £220 million development • 3rd largest cancer centre in the UK (66,000m2, 350 beds) • Unites cancer surgery, non-surgical oncology, pathology, radiology • Leeds Institute of Molecular Medicine – laboratory research • £21M development, opened 2005 • >7,000m2 building linked to existing research laboratories
  • 10. Leeds Cancer Centre – clinical care • 12,500 new cancer diagnoses • 6,500 radiotherapy patients • 90,000 fractions of radiotherapy • 5,000 cycles of chemotherapy • 11,700 elective NSO admissions • 3,500 acute NSO admissions • Specialist surgery • 38 Site specific MDTs • 250 oncology specialists • 31 clinical oncologists • 24 medical oncologists • 22 haematologists • 33 histopathologists • 42 radiologists • 70+ surgeons • 430 consultants in MDTs • 1240 nurses
  • 11. Leeds Cancer Centre – clinical and academic research • Cancer Research UK Centre • Director – Prof Tim Bishop • Genetics and epigenetics of cancer • Targeted therapies • Early phase and randomised prospective clinical trials • Biomarkers and pathology • Leeds Institute of Molecular Medicine • Director – Prof Peter Selby • Genetics; Molecular Gastroenterology, Neurosciences • Experimental Cancer Therapeutics • Experimental Haematology • Targeted Cancer Therapies • Cancer Pathology, Tumour Biology
  • 12. Leeds Cancer Centre and Jordan • Nov 2012 approach from UK Trade & Investment • Would Leeds consider a collaboration with King Hussein Cancer Centre, Amman, Jordan ? • Established cancer centre • “Leading comprehensive cancer centre in Middle East” • Provides cancer services to Jordan • 30% of patients from Middle East • Iraq, Syria, Lebanon
  • 13. King Hussein Cancer Centre, Amman, Jordan
  • 14. King Hussein Cancer Centre, Amman, Jordan • Plans for expansion • ↑ cases from 3000 to 9000 / year • ↑ beds from 170 to 352 • Ambition to • ↑ research • ↑ molecular diagnostics
  • 15. Collaboration with KHCC – for mutual benefit • Could we support training and education in Amman ? • Medical and non-medical staff • Short term observation posts • 6 month to 1 year fellow ships • KHCC to send fully funded Jordanian trainees to Leeds • 17 medical posts covering all aspects of oncology • Programme of specialist oncology training for nursing staff
  • 16. Collaboration with KHCC – for mutual benefit • Could we support their quality programme ? • Review of clinical services at KHCC • According to UK peer review • Combined with seminars from visiting experts • Leeds team to support Peer Review in Jordan • Education re process from Leeds and National teams • KHCC team to observe External Peer Review in Leeds • 5-year programme to deliver External Peer Review in Amman
  • 17. Collaboration with KHCC – for mutual benefit • Could we support clinical research ? • Joint clinical trial protocols • Training for research staff • Advice on regulatory process • Support development of research team • Joint proposal to AACR / EORTC Flims Workshop
  • 18. Collaboration with KHCC – for mutual benefit • Could we support academic research ? • Host Jordanian trainees in CR-UK labs • Support development of molecular diagnostics • Support development of cancer genetics service • Deliver molecular diagnostics for KHCC • Support and develop molecular diagnostics • Offer research positions to KHCC trainees • Exploring potential to develop funded research positions
  • 19. Collaboration with KHCC – for mutual benefit • Could we collaborate with Clinical informatics ? • Shared interest in open-source EPR • PPM, the Leeds EPR underpins recent MRC award • Collaboration with Leeds and CR-UK to share website • Support Arabic translation of cancer information • Develop common methods to analyse outcomes
  • 20. Collaboration with KHCC – for mutual benefit • Could we support clinical management ? • Virtual MDTs • Transfer of complex patients to Leeds • Exploring CISCO solution to deliver common platform • Transfer of digital radiology plus review of histology • Transfer of digital pathology
  • 21. Collaboration with KHCC – for mutual benefit • Timeline • Nov 2012, initial visit to KHCC by Leeds • June 2013, return visit to Leeds Cancer Centre • October 2013, memorandum of understanding signed • KHCC and Cancer Foundation • Leeds Cancer Centre • British Embassy, Jordan & Healthcare UK • December 2013, second visit to Amman • Peer review in gynae cancer • Expert lecture in gynae cancer • Development of training plans
  • 22. Summary • King Hussein Cancer Centre, Jordan • Has world-class cancer facilities • Offers world-class cancer care • Leeds Cancer Centre • Offer support in clinical management • Support training and education • Support development of clinical and academic research • Deliver and support development of quality programme
  • 23. Global opportunities in public health Dr David Rhodes Public Health England
  • 24. International opportunities in public health – what have we learned? David Rhodes, Deputy Director & Head of Business Development
  • 25. Sender bodies The existing health organisations and functions that contributed some or all of their staff to Public Health England include: – Health Protection Agency – National Treatment Agency – Department of Health – Strategic Health Authorities – Primary Care Trusts – Public health observatories – Cancer registries – National cancer intelligence network 25 Opportunities in public health – Quality assurance reference centres (QARCS) – Specialist dental commissioners – Specialist commissioners – NHS cancer screening programme – UK national screening programmes (non-cancer)
  • 26. Mission and priorities 26 Opportunities in public health “To protect and improve the nation’s health and to address inequalities, working with national and local government, the NHS, industry, academia, the public and the voluntary and community sector.”
  • 27. The three domains of public health 27 Opportunities in public health – Inequalities – Education – Housing – Employment – Family/community – Lifestyles – Surveillance and monitoring of specific diseases and risk factors – Clinical effectiveness – Efficiency – Service planning – Audit and evaluation – Clinical governance – Equity – Infectious diseases – Chemicals and poisons – Radiation – Emergency response – Environmental health hazards Health Improvement Health Protection Healthcare Public Health * Definitions from the Faculty of Public Health, 2013
  • 28. PHE
  • 29. External income External income by category Innovations Services Products • Spinout company Syntaxin valued at ~£100m • Sterilisation technology licensed to BiotAK, Voraxase to BTG, polio vaccine to GSK • Specialist training delivered in UK and overseas • Biological materials and quality assurance schemes distributed internationally • Development contracts with US and European vaccine companies Opportunities in public health 29
  • 30. NorthAmerica • Vibrant healthcare sector • Strong government support • US Government prime contractor status and FARs • Commitment to infectious disease sector 30Opportunities in public health
  • 31. Europe • Stable European Union funding sources • Some limitations to cost recovery • Strong life sciences sector 31Opportunities in public health
  • 32. International commercial opportunities • Trade events and missions • Need for strong governance framework • Support from UKTI, Healthcare UK, embassies and consulates • Transactional costs can be high • Need for good websites 32Opportunities in public health
  • 33. International interest in public health 33Opportunities in public health
  • 34. Barriers to be overcome • Marketing and transactional resources • Local representation • Understanding procurement regulations • Overseas legal jurisdictions • Language barriers generally manageable 34Opportunities in public health
  • 35. Recent highlights • Several key contracts and opportunities in Gulf states • 2012 Olympics experience in mass gathering medicine now offered internationally • Microbiology training in former Soviet Union countries • Trade missions to Saudi Arabia, Qatar, Brazil, India and China • MoUs announced last week during India trade mission with Jawaharlal Institute of Postgraduate Medical Education and Research and Public Health Foundation of India • Opportunities for joint and collaborative funding 35Opportunities in public health
  • 36. Lessons learned • Need for a ruthless focus on what adds value to both parties • Requires strong governance and management processes • Lack of resources “on the ground” will necessitate external support • International opportunities are very real and bring real benefits • not least in market testing our cost-effectiveness 36Opportunities in public health
  • 37. Observations and opportunities: a perspective from Hong Kong Professor Sian M Griffiths OBE JP MB BChir( Cantab),FFPHM, FHKCCM, FRCP, FRCSD Sector Specialist for Healthcare UK Emeritus Professor , Chinese University of Hong Kong Visiting Professor , Imperial College , London Senior Adviser on International academic development , CUHK
  • 38. Hong Kong
  • 39. 39 SARS siangriffiths@cuhk.edu.hk march 2014
  • 40. Lessons from SARS siangriffiths@cuhk.edu.hk march 2014 •Communication • Collaboration •Cooperation •Capacity
  • 41. siangriffiths@cuhk.edu.hk march 2014
  • 42. siangriffiths@cuhk.edu.hk march 2014
  • 43. Healthcare in Hong Kong siangriffiths@cuhk.edu.hk march 2014
  • 44. siangriffiths@cuhk.edu.hk march 2014
  • 45. Health Care in Hong Kong: The Hospital Authority siangriffiths@cuhk.edu.hk march 2014 45
  • 46. 2014-15 Budget Highlights – 26th Feb • Over the past 5 years, the Government’s recurrent allocation to the Health Authority has increased by $15billion, or nearly 50% – the total recurrent provision for 2014/15 exceeds $47 billion • Hospital redevelopment – New builds as well as upgrading facilities http://www.budget.gov.hk/2014/eng/budget34.htm siangriffiths@cuhk.edu.hk march 2014
  • 47. Public hospital building programme • HK$55 billion to enhance hospitals . – the new Tin Shui Wai Hospital – Hong Kong Children's Hospital – redeveloping Kwong Wah Hospital, Queen Mary Hospital and Kwai Chung Hospital, – expanding the United Christian Hospital and Red Cross Blood Transfusion Service Headquarters. It will add 1,400 hospital beds. • The government is also studying on the construction of an acute general hospital in the Kai Tak Development Area. siangriffiths@cuhk.edu.hk march 2014
  • 48. Improving and upgrading facilities • renovation of over 500 wards in 34 hospitals • provision of around 800 additional beds in 11 hospital • expansion of operating theatres, accident and emergency departments, and general out-patient clinics • setting up additional endoscopy centres and ambulatory facilities • comprehensively upgrade the major electrical and mechanical engineering installations in hospitals • strengthen the Universal Accessibility Programme It is estimated that the grant will be used to implement about 5,000 projects siangriffiths@cuhk.edu.hk march 2014
  • 49. Increased funding for elderly services • Strengthen support for frail elderly persons living at home; increase rehabilitation • upgrading 51 social centres for the elderly to neighbourhood elderly centres • enable all subvented elderly centres to increase their manpower as well as programme expenses • enhance care and support for the elderly in nursing homes as well as more places • purchase of residential care places from elderly homes run by Hong Kong non-governmental organisations in the Mainland. • Consider vouchers siangriffiths@cuhk.edu.hk march 2014
  • 50. PPP: increasing the private sector • Sustainable development of our dual-track healthcare system, • Government is considering a voluntary health protection scheme to encourage those who can afford it to make greater use of private healthcare services • Consider providing tax reliefs for subscribers of regulated insurance products after a consensus is reached in the community. siangriffiths@cuhk.edu.hk march 2014
  • 51. Prevention and primary care • Disease prevention and control forms an important line of defence in public health. • Government has endeavoured to strengthen primary care, including proactively promoting healthy living, as well as strengthening disease prevention strategies and surveillance systems, with a view to lowering risks of disease and hence expenditure on healthcare. • In the coming five years, Government will allocate additional funding of over $420 million for the study and implementation of a pilot programme to subsidise colorectal cancer screening for specific age groups. siangriffiths@cuhk.edu.hk march 2014
  • 52. Tobacco control • Increase the duty on cigarettes by 20 cents per stick with immediate effect. • This will bring the proportion of tobacco duty to the retail price of cigarettes to about 70% – meets the minimum level recommended by WHO. • Not a budgetary measure to increase revenue – continue to strengthen smoking cessation services, – publicity and law enforcement on tobacco control. • The Customs and Excise Department will step up enforcement against different forms of illicit cigarette trading. siangriffiths@cuhk.edu.hk march 2014
  • 53. Opportunities siangriffiths@cuhk.edu.hk march 2014 •Communication • Collaboration •Cooperation •Capacity
  • 54. Thank you for listening ! siangriffiths@cuhk.edu.hk march 2014 “Manpower, land supply and an ageing population are the major constraints to Hong Kong’s future development. To overcome them, we must endeavour to nurture a wealth of suitable talent for the future, increase land supply to expand the scale of the economy, and plan well ahead for an ageing society. ”
  • 55. Panel Discussion and Q&A Moderator : Prof Rory Shaw Panellists: Dr Geoff Hall Dr David Rhodes Professor Sian M Griffiths
  • 56. Summary
  • 57. The vital partner in global health
  • 58. Seminar S169 Taking NHS expertise overseas – preparation, prospects and pitfalls Chairman: Professor Rory Shaw MD MBA FRCP Medical Director Healthcare UK